Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-24 @ 11:24 PM
NCT ID:
NCT01999556
Eligibility Criteria:
Inclusion Criteria
* Patients must have a diagnosis of acute myelogenous leukemia.
* Family members of patients with acute myelogenous leukemia may be enrolled.
* Informed consent must be provided by the patient or his/her legal guardian in accord with the practices of Levine Cancer Institute and Atrium Health.
Exclusion Criteria
* Known infection with Hepatitis B or C, HTLV, or HIV.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01999556
Study Brief:
Protocol Section:
NCT01999556